Authors: McLaughlin, PMJ Harmsen, MC Dokter, WHA Kroesen, BJ van der Molen, H Brinker, MGL Hollema, H Ruiters, MHJ Buys, CHCM de Leij, LFMH

Citation: Pmj. Mclaughlin et al., The epithelial glycoprotein 2 (EGP-2) promoter-driven epithelial-specific expression of EGP-2 in transgenic mice: A new model to study carcinoma-directed immunotherapy, CANCER RES, 61(10), 2001, pp. 4105-4111

Authors: Schuringa, JJ Jonk, LJC Dokter, WHA Vellenga, E Kruijer, W

Citation: Jj. Schuringa et al., Interleukin-6-induced STAT3 transactivation and Ser(727) phosphorylation involves Vav, Rac-1 and the kinase SEK-1/MKK-4 as signal transduction components, BIOCHEM J, 347, 2000, pp. 89-96

Authors: Birkenkamp, KU Dokter, WHA Esselink, MT Jonk, LJC Kruijer, W Vellenga, E

Citation: Ku. Birkenkamp et al., A dual function for p38 MAP kinase in hematopoietic cells: involvement in apoptosis and cell activation, LEUKEMIA, 13(7), 1999, pp. 1037-1045

Authors: McLaughlin, PMJ Kroesen, BJ Dokter, WHA van der Molen, H de Groot, M Brinker, MGL Kok, K Ruiters, MHJ Buys, CHCM de Leij, LFMH

Citation: Pmj. Mclaughlin et al., An EGP-2/Ep-CAM-expressing transgenic rat model to evaluate antibody-mediated immunotherapy, CANCER IMMU, 48(6), 1999, pp. 303-311

Authors: Tuyt, LML Dokter, WHA Birbenkamp, K Koopmans, SB Lummen, C Kruijer, W Vellenga, E

Citation: Lml. Tuyt et al., Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are involved in NF-kappa B-dependent IL-6 expression in human monocytes, J IMMUNOL, 162(8), 1999, pp. 4893-4902